165 related articles for article (PubMed ID: 6165806)
1. Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain.
Edwards DJ; Rizk M
J Neurochem; 1981 May; 36(5):1641-7. PubMed ID: 6165806
[TBL] [Abstract][Full Text] [Related]
2. Rat brain and plasma norepinephrine glycol metabolites determined by gas chromatography-mass fragmentography.
Warsh JJ; Godse DD; Cheung SW; Li PP
J Neurochem; 1981 Mar; 36(3):893-901. PubMed ID: 7205279
[TBL] [Abstract][Full Text] [Related]
3. Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine.
Edwards DJ; Rizk M; Spiker DG
Biochem Med; 1981 Apr; 25(2):135-48. PubMed ID: 6169341
[No Abstract] [Full Text] [Related]
4. Rat brain norepinephrine metabolism: substantial clearance through 3,4-dihydroxyphenylethyleneglycol formation.
Li PP; Warsh JJ; Godse DD
J Neurochem; 1983 Oct; 41(4):1065-71. PubMed ID: 6619846
[TBL] [Abstract][Full Text] [Related]
5. Relative importance of 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol as norepinephrine metabolites in rat, monkey, and humans.
Elsworth JD; Roth RH; Redmond DE
J Neurochem; 1983 Sep; 41(3):786-93. PubMed ID: 6875564
[TBL] [Abstract][Full Text] [Related]
6. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.
Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS
J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731
[TBL] [Abstract][Full Text] [Related]
7. Postmortem stability of brain 3-methoxy-4-hydroxyphenylethyleneglycol and 3,4-dihydroxyphenylethyleneglycol in the rat and mouse.
Warsh JJ; Godse DD; Li PP; Cheung SW
J Neurochem; 1981 Mar; 36(3):902-7. PubMed ID: 7205280
[TBL] [Abstract][Full Text] [Related]
8. Formation and clearance of norepinephrine glycol metabolites in mouse brain.
Li PP; Warsh JJ; Godse DD
J Neurochem; 1984 Nov; 43(5):1425-33. PubMed ID: 6491661
[TBL] [Abstract][Full Text] [Related]
9. Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.
Edwards DJ; Ravitch J; Knopf S; Sedlock ML
Biochem Pharmacol; 1985 Apr; 34(8):1255-63. PubMed ID: 2581581
[TBL] [Abstract][Full Text] [Related]
10. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
11. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
[TBL] [Abstract][Full Text] [Related]
12. Further characterization of brain 3,4-dihydroxyphenylethyleneglycol (DHPG) formation: dependence on noradrenergic activity and site of formation.
Li PP; Warsh JJ; Godse DD
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):26-33. PubMed ID: 3951564
[TBL] [Abstract][Full Text] [Related]
13. Is 3,4-dihydroxyphenylglycol the major route of central norepinephrine metabolism in rat brain?
Karege F; Gaillard JM
Neurosci Lett; 1986 Aug; 69(1):78-83. PubMed ID: 3748468
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-induced regional changes in brain noradrenaline and dopamine turnover in rats.
Kubo T; Amano H; Kurahashi K; Misu Y
J Pharmacobiodyn; 1989 Feb; 12(2):107-12. PubMed ID: 2501470
[TBL] [Abstract][Full Text] [Related]
15. Interspecies differences in the metabolism of brain norepinephrine to glycol metabolites.
Li PP; Warsh JJ; Godse DD; Guttman M
Neurochem Int; 1987; 10(4):537-45. PubMed ID: 20501128
[TBL] [Abstract][Full Text] [Related]
16. Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.
Wilner KD; Butler IJ; Seifert WE; Clement-Cormier YC
Biochem Pharmacol; 1980 Mar; 29(5):701-6. PubMed ID: 20227943
[TBL] [Abstract][Full Text] [Related]
17. Increase of catecholamines in mouse brain by systemic administration of gamma-glutamyl L-3,4-dihydroxyphenylalanine.
Ichinose H; Togari A; Suzuki H; Kumagai H; Nagatsu T
J Neurochem; 1987 Sep; 49(3):928-32. PubMed ID: 3112308
[TBL] [Abstract][Full Text] [Related]
18. Brain cortical tissue levels of noradrenaline and its glycol metabolites: effects of ischemia and postischemic administration of idazoxan.
Gustafson I; Lidén A; Wieloch T
Exp Brain Res; 1992; 90(3):551-6. PubMed ID: 1358670
[TBL] [Abstract][Full Text] [Related]
19. Measurement of tritiated norepinephrine metabolism in intact rat brain.
Levitt M; Kowalik S; Barkai AI
J Neurosci Methods; 1983 Jun; 8(2):155-60. PubMed ID: 6876877
[TBL] [Abstract][Full Text] [Related]
20. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
